on-interventional long-term follow-up observation of patients after successful catheter related blood stream infection (CRBSI) treatment with Geistlich TauroSept®
- Conditions
- infection-free catheter instillation time after successful catheter infection treatment with Geistlich TauroSept® in a previous clinical investigation.
- Registration Number
- DRKS00026073
- Lead Sponsor
- Geistlich Pharma AG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting withdrawn before recruiting started
- Sex
- All
- Target Recruitment
- 20
•Written informed consent
•Successful CRBSI treatment in the previous multicenter PMCF investigation
•Final assessment of the previous PMCF investigation completed
•Newly diagnosed diseases/conditions affecting the functionality of the catheter/ needing catheter removal intervention
•Severe trauma of the catheter site
•Participation in a clinical investigation interfering with the objective of this non-interventional long-term follow-up observation
•Use of catheter lock solution (CLS) containing taurolidine since the end of the Geistlich TauroSept treatment in the previous PMCF investigation
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method infection-free catheter instillation time
- Secondary Outcome Measures
Name Time Method Different catheter complication parameters
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.